Skip to main content
Clinical Trials/NCT02175316
NCT02175316
Completed
Not Applicable

Effects of Enhanced External Counterpulsation on Delayed Onset Muscle Soreness, a Pilot Study

David Grant U.S. Air Force Medical Center1 site in 1 country18 target enrollmentStarted: April 2014Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
David Grant U.S. Air Force Medical Center
Enrollment
18
Locations
1
Primary Endpoint
Change in delayed onset muscle soreness over time.

Overview

Brief Summary

This study will evaluate the effects of Enhanced External Counterpulsation on delayed onset muscle soreness. The primary outcomes will be duration of delayed onset muscle soreness, WBC count, CRP count, CPK count, and pain tolerance.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
25 Years to 59 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Healthy active Duty or DoD beneficiaries between 25 and 59 years old

Exclusion Criteria

  • Not on a physical profile
  • Not taking any OTC or prescription pain medications or workout supplements

Outcomes

Primary Outcomes

Change in delayed onset muscle soreness over time.

Time Frame: At 3, 6, 9, 12, 15, 21, 24, 27, 30, 33, 36, 39, 42, 45, 48 Hours

Likert pain surveys

Secondary Outcomes

  • Bio-markers for muscle inflammation(Baseline, 24 hours, 2 days 3 days 4 days 33 days)
  • Pain tolerance(Baseline, 24 hours, 2 days 3 days 4 days 33 days)

Investigators

Sponsor
David Grant U.S. Air Force Medical Center
Sponsor Class
Fed
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials